Search
Search Results
##search.searchResults.foundPlural##
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2450PDF: 1905HTML: 1065 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9457PDF: 6279HTML: 88281Fig.1b: 272Fig.1c: 279Fig.2a: 272Fig.2b: 260Fig.4: 287Fig.2c: 253Fig.3: 263Tab.1: 324Tab.2: 302Tab.3: 287Tab.4: 331Fig1a: 275 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
3050PDF: 1357HTML: 2846Figure 1: 224 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1995PDF: 893HTML: 10370Figures 1,2,3: 283 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
3259PDF: 954HTML: 6625Untitled: 291Untitled: 247Untitled: 265Untitled: 274 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
3079PDF: 1092HTML: 5667 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4733PDF: 3909HTML: 382 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4460PDF: 2041HTML: 5549Table 1: 289 -
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
3340PDF: 1186HTML: 1996 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2121PDF: 834HTML: 733Table1: patient's characteristics: 239Table 2: profile of each patient: 234 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3868PDF: 975HTML: 6889 -
POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.
1244PDF: 654Suppl. Files: 153HTML: 545 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3653PDF: 974HTML: 1706figure 1: 209Untitled: 236 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1886PDF: 1259HTML: 360 -
A STUDY ON THE EXPRESSION OF BCR-ABL TRANSCRIPT IN MIXED PHENOTYPE ACUTE LEUKEMIA (MPAL) CASES USING THE REVERSE TRANSCRIPTASE POLYMERASE REACTION ASSAY (RT-PCR) AND ITS CORRELATION WITH HEMATOLOGICAL REMISSION STATUS POST INITIAL INDUCTION THERAPY
1468PDF: 924HTML: 5096INSTITUTE PUBLICATION COMMITTEE APPROVAL: 212 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3464PDF: 1042HTML: 3023 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2418PDF: 890HTML: 1707Figure 1: 259Table 1: 258 -
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS
1644PDF: 982HTML: 2015Figure: 220Tables: 231ALL revision 1: 331response to reviewer: 229 -
ASSOCIATION OF BASELINE PLATELET COUNT WITH COMPLETE REMISSION, SEVERE BLEEDING, AND 24-MONTH OVERALL SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: A SINGLE-CENTER RETROSPECTIVE COHORT STUDY
135PDF: 102Suppl. Files: 24Html: 24Html Suppl. Files: 22 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
2276PDF: 901HTML: 270 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3978PDF: 1768HTML: 11948Figures Haase: 289 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1729HTML: 708PDF: 925 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2626PDF: 862HTML: 1756 -
ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS Anorectal pathologies in leukemias
1309PDF: 805Html: 127 -
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience. Coagulopathy in APL treated with ATRA and Arsenic Trioxide.
1264PDF: 1183HTML: 514 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2668PDF: 1270HTML: 1095 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4606PDF: 1832HTML: 1130







